Asean Research
Compliant
Focus Point Sustainable Growth Ahead; Keep BUY
Consumer Cyclical | Consumer Products
Target Price (Return): MYR0.74 (35.8%)
Price (Market Cap): MYR0.55 (USD79.5m)
ESG score: 2.9 (out of 4)
Avg Daily Turnover (MYR/USD): 0.11m/0.03m
Buy (Maintained)
Analysts
Tai Yu Jie
+603 2302 8132
tai.yu.jie@rhbgroup.com
Soong Wei Siang
+603 2302 8130
soong.wei.siang@rhbgroup.com
Summary
- Keep BUY, MYR0.74 TP (adjusted post bonus issue), 36% upside and c.6% FY26F (Jun) yield. Focus Point’s 1H25 results met expectations. We believe growth momentum is sustainable, supported by higher volumes from store expansion, effective marketing initiatives, increasing optical corporate sales, and continued GPM expansion. The stock is trading at a single-digit valuation and remains the cheapest among consumer retailers under our coverage, which we see as unwarranted given its market leadership and consistent record of outperforming the broader retail sector.
- Within expectations. 1H25 core profit of MYR16.6m (+4.5% YoY) met 46% and 44% of our and consensus full-year forecasts. The results are in line with expectations, as we expect a stronger 2H25 due to seasonal factors.
- Results review. YoY, 1H25 revenue grew 4.9% to MYR145.7m, mainly driven by growth in the optical segment (+5.3%) from store expansion (five owned and one franchised stores) and SSSG of less than 5%. 1H25 GPM expanded 1.9ppts YoY to 67.2%, supported by stronger bargaining power from higher volumes. Consequently, 1H25 PBT rose 3.4% YoY to MYR22.1m, with stronger optical performance (+16.1%) offset by the F&B segment, which slipped back into a loss of MYR1.6m (vs 1H24 PBT: MYR0.6m) due to cautious consumer sentiment and rising opex. QoQ, 2Q25 revenue was flattish at MYR72.8m (-0.2%) on less aggressive price promotions, but improved GPM (+1.3ppts to 67.8%) lifted core profit 12% QoQ to MYR8.8m.
- Outlook. Focus Point is well-positioned to capture the rising myopic population, leveraging its market leadership and strong brand equity. The group will continue to drive effective marketing initiatives and expand into East Malaysia – where competition is relatively limited – to further grow market share. Corporate sales (7% of optical revenue) are also expected to sustain strong growth (1H25: +>70% YoY), supported by rising demand from employers offering optical benefits to attract and retain talent. With higher sales volumes and stronger bargaining power, GPM expansion should be sustainable to offset the rising opex environment. In the F&B segment, management is in discussions to secure new business and ramp up central kitchen utilisation, while Komugi’s expansion will remain prudent amid subdued consumer sentiment.
- Forecast and ratings. Post results, we maintain our earnings forecasts with a DCF-derived MYR0.74 TP (includes a 2% ESG discount), which implies 11.4x FY26F P/E, or +1SD from the mean. This is in line with the valuation ascribed to other consumer retail stocks under our coverage.
- Key downside risks: Major delays in expansion plans and a loss of key corporate customers in the F&B segment.
Share Performance (%)
YTD | 1m | 3m | 6m | 12m | |
---|---|---|---|---|---|
Absolute | (9.8) | (0.6) | (7.5) | (7.5) | (8.6) |
Relative | (6.6) | (4.8) | (9.7) | (8.1) | (5.0) |
52-wk Price low/high (MYR) 0.53-0.63
FOCUSP MK (FOCUSP MK) Price Chart (Textual Representation)
A hypothetical price chart showing “Price Close” and “Relative to FBM KLCI (RHS)” over time from Aug-24 to Aug-25, with price range from 0.52 to 0.64 on the left axis and relative index from 95 to 112 on the right axis. The trend shows fluctuations but generally remains within the 0.52-0.64 range for price and 95-112 for relative index.
Source: Bloomberg
Forecasts and Valuation
Dec-23 | Dec-24 | Dec-25F | Dec-26F | Dec-27F | |
---|---|---|---|---|---|
Total turnover (MYRm) | 261 | 293 | 327 | 356 | 384 |
Recurring net profit (MYRm) | 33 | 33 | 36 | 40 | 44 |
Recurring net profit growth (%) | (9.2) | 1.5 | 7.9 | 11.5 | 9.4 |
Recurring P/E (x) | 10.25 | 10.10 | 9.36 | 8.40 | 7.68 |
P/B (x) | 2.8 | 2.5 | 2.2 | 1.9 | 1.7 |
P/CF (x) | 5.45 | 5.16 | 3.88 | 3.45 | 2.92 |
Dividend Yield (%) | 5.5 | 6.4 | 5.3 | 6.0 | 6.5 |
EV/EBITDA (x) | 3.62 | 3.55 | 3.35 | 2.69 | 2.14 |
Return on average equity (%) | 27.4 | 26.2 | 24.9 | 24.5 | 23.8 |
Net debt to equity (%) | net cash | net cash | net cash | net cash | net cash |
Overall ESG Score: 2.9 (out of 4)
E Score: 2.3 (GOOD)
S Score: 4.0 (EXCELLENT)
G Score: 3.0 (GOOD)
Note:
Please refer to the ESG analysis on the next page
Small cap stocks are defined as companies with a market capitalisation of less than USD0.5bn.
Source: Company data, RHB
See important disclosures at the end of this report
Emissions And ESG
Trend analysis
Emissions (tCO2e) | Dec-22 | Dec-23 | Dec-24 | Dec-25 |
---|---|---|---|---|
Scope 1 | 210 | 226 | ||
Scope 2 | 1,697 | 1,853 | ||
Scope 3 | 1,174 | |||
Total emissions | na | 1,907 | 3,253 | na |
Source: Company data, RHB
Latest ESG-Related Developments
By expanding the scope of carbon emissions reporting to include Scope 3 and enhancing data tracking, Focus Point is taking a holistic approach to understanding the environmental impact.
This reflects its ongoing commitment to transparency and its belief that even small, consistent actions whether in reducing energy usage, or refining travel and commuting practices can lead to meaningful, lasting change.
ESG Unbundled
Last Updated: 23 May 2025
In response to decarbonisation efforts and a commitment to a net-zero economy, the group has enhanced energy efficiency and reduced its carbon footprint. The group has started disclosing emission data for FY23.
The group prioritises employee health and safety to minimise work-related accidents. It upholds human rights, supports talent development, and promotes diversity and inclusion. FPHB’s foundation conducts charitable initiatives and provides vision screening and eyewear to students in need.
FPHB maintains strong corporate governance with policies including equal opportunity, anti-bribery, personal data protection, and a code of conduct. It adheres to the Malaysian Code on Corporate Governance (MCCG), with a Board comprising 50% independent directors and meeting the 30% women directors recommendation.
ESG Rating History (Textual Representation)
A visual representation of ESG rating history from Aug-23 to Aug-25, showing ratings of 2.8, 2.9, 2.9, 2.9, 2.9, 2.9. The rating appears to be stable around 2.9 after an initial 2.8.
Source: RHB
See important disclosures at the end of this report
Financial Exhibits
Financial summary (MYR)
Dec-23 | Dec-24 | Dec-25F | Dec-26F | Dec-27F | |
---|---|---|---|---|---|
Recurring EPS | 0.05 | 0.05 | 0.06 | 0.06 | 0.07 |
DPS | 0.03 | 0.04 | 0.03 | 0.03 | 0.04 |
BVPS | 0.19 | 0.22 | 0.25 | 0.28 | 0.32 |
Return on average equity (%) | 27.4 | 26.2 | 24.9 | 24.5 | 23.8 |
Valuation metrics
Dec-23 | Dec-24 | Dec-25F | Dec-26F | Dec-27F | |
---|---|---|---|---|---|
Recurring P/E (x) | 10.25 | 10.10 | 9.36 | 8.40 | 7.68 |
P/B (x) | 2.8 | 2.5 | 2.2 | 1.9 | 1.7 |
FCF Yield (%) | 16.0 | 15.2 | 19.8 | 23.0 | 26.8 |
Dividend Yield (%) | 5.5 | 6.4 | 5.3 | 6.0 | 6.5 |
EV/EBITDA (x) | 3.62 | 3.55 | 3.35 | 2.69 | 2.14 |
EV/EBIT (x) | 6.99 | 6.88 | 6.34 | 5.54 | 4.77 |
Income statement (MYRm)
Dec-23 | Dec-24 | Dec-25F | Dec-26F | Dec-27F | |
---|---|---|---|---|---|
Total turnover | 261 | 293 | 327 | 356 | 384 |
Gross profit | 169 | 187 | 214 | 232 | 250 |
EBITDA | 91 | 94 | 98 | 117 | 136 |
Depreciation and amortisation | (44) | (45) | (46) | (60) | (75) |
Operating profit | 47 | 48 | 52 | 57 | 61 |
Net interest | (5) | (5) | (5) | (4) | (3) |
Pre-tax profit | 40 | 44 | 47 | 53 | 58 |
Taxation | (10) | (11) | (11) | (13) | (14) |
Reported net profit | 30 | 33 | 36 | 40 | 44 |
Recurring net profit | 33 | 33 | 36 | 40 | 44 |
Cash flow (MYRm)
Dec-23 | Dec-24 | Dec-25F | Dec-26F | Dec-27F | |
---|---|---|---|---|---|
Change in working capital | (15.7) | (16.8) | (0.2) | (7.4) | (6.9) |
Cash flow from operations | 61.6 | 65.1 | 86.6 | 97.3 | 115.0 |
Capex | (7.9) | (14.2) | (20.0) | (20.0) | (25.0) |
Cash flow from investing activities | 1.1 | (9.1) | (20.0) | (20.0) | (25.0) |
Dividends paid | (13.9) | (16.2) | (17.9) | (20.0) | (21.9) |
Cash flow from financing activities | (64.7) | (54.0) | (63.3) | (64.2) | (65.2) |
Cash at beginning of period | 54.0 | 39.4 | 38.5 | 41.8 | 54.9 |
Net change in cash | (2.0) | 2.0 | 3.3 | 13.1 | 24.7 |
Ending balance cash | 51.9 | 41.4 | 41.8 | 54.9 | 79.6 |
Balance sheet (MYRm)
Dec-23 | Dec-24 | Dec-25F | Dec-26F | Dec-27F | |
---|---|---|---|---|---|
Total cash and equivalents | 39 | 39 | 42 | 55 | 80 |
Tangible fixed assets | 137 | 144 | 158 | 157 | 148 |
Total investments | 3 | 1 | 1 | 1 | 1 |
Total assets | 283 | 288 | 315 | 338 | 362 |
Short-term debt | 18 | 18 | 18 | 18 | 18 |
Total long-term debt | 17 | 17 | 17 | 17 | 17 |
Total liabilities | 165 | 153 | 162 | 165 | 167 |
Total equity | 118 | 135 | 153 | 173 | 195 |
Total liabilities & equity | 283 | 288 | 315 | 338 | 362 |
Key metrics
Dec-23 | Dec-24 | Dec-25F | Dec-26F | Dec-27F | |
---|---|---|---|---|---|
Revenue growth (%) | 4.9 | 12.1 | 11.8 | 8.9 | 7.9 |
Recurrent EPS growth (%) | (9.2) | 1.5 | 7.9 | 11.5 | 9.4 |
Gross margin (%) | 64.9 | 63.8 | 65.3 | 65.1 | 65.1 |
Operating EBITDA margin (%) | 34.8 | 32.0 | 30.0 | 33.0 | 35.4 |
Net profit margin (%) | 11.6 | 11.3 | 11.0 | 11.2 | 11.4 |
Dividend payout ratio (%) | 61.3 | 65.0 | 50.0 | 50.0 | 50.0 |
Capex/sales (%) | 3.0 | 4.9 | 6.1 | 5.6 | 6.5 |
Interest cover (x) | 7.65 | 7.54 | 8.06 | 8.84 | 9.47 |
Source: Company data, RHB
See important disclosures at the end of this report
Results At a Glance
Figure 1: Earnings review
FYE Dec (MYRm) | 2Q24 | 1Q25 | 2Q25 | QoQ (%) | YoY (%) | 1H24 | 1H25 | YoY (%) | Comments |
---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Optical and related products | 58.7 | 61.1 | 60.6 | (0.7) | 3.3 | 115.5 | 121.7 | 5.3 | Store expansion and solid SSSG |
Food and beverage | 10.9 | 10.9 | 11.1 | 2.2 | 1.7 | 21.3 | 22.0 | 3.3 | |
Others | 1.0 | 1.0 | 1.1 | 5.0 | 5.8 | 2.1 | 2.1 | (2.2) | |
Total | 70.6 | 72.9 | 72.8 | (0.2) | 3.1 | 138.9 | 145.7 | 4.9 | |
PBT | |||||||||
Optical and related products | 11.0 | 11.6 | 12.6 | 8.6 | 14.9 | 20.9 | 24.2 | 16.1 | Supported by solid sales momentum and GPM expansion |
Food and beverage | 0.7 | (0.7) | (0.8) | N.m. | N.m. | 0.6 | (1.6) | N.m. | Slipped into loss on cautious consumer sentiment and rising opex environment |
Others | (0.3) | (0.2) | (0.3) | 25.1 | 3.4 | (0.1) | (0.5) | 972.5 | |
Total | 11.4 | 10.6 | 11.5 | 0.1 | 0.0 | 21.4 | 22.1 | 3.4 | |
PBT margin | |||||||||
Optical and related products | 18.7 | 19.0 | 20.8 | 1.8 | 2.1 | 18.1 | 19.9 | 1.8 | |
Food and beverage | 6.2 | (6.8) | (7.5) | (0.7) | (13.7) | 2.6 | (7.2) | (9.8) | |
Others | (29.4) | (24.1) | (28.7) | (4.6) | 0.7 | (2.4) | (26.5) | (24.1) | |
Total | 16.1 | 14.6 | 15.8 | 1.2 | (0.3) | 15.4 | 15.2 | (0.2) |
Source: Company data, RHB
See important disclosures at the end of this report
DCF Valuation
Figure 3: DCF valuation
FYE Dec | FY26F | FY27F | FY28F | FY29F | FY30F | FY31F | FY32F | FY33F | FY34F | FY35F |
---|---|---|---|---|---|---|---|---|---|---|
EBIT | 57 | 61 | 65 | 68 | 72 | 75 | 78 | 80 | 82 | 85 |
EBIT*(1-tax rate) | 44 | 47 | 50 | 52 | 54 | 55 | 56 | 57 | 58 | 58 |
Add: D&A | 4 | 4 | 5 | 5 | 6 | 6 | 7 | 8 | 9 | 10 |
Less: WC investments (WC Inv) | -7 | -7 | -7 | -7 | -8 | -8 | -9 | -9 | -10 | -10 |
Less: Fixed investments (FC Inv) | -20 | -25 | -25 | -30 | -30 | -35 | -35 | -35 | -35 | -35 |
FCFF | 21 | 19 | 22 | 19 | 21 | 18 | 20 | 21 | 22 | 23 |
Disc. FCFF | 20 | 17 | 19 | 16 | 16 | 13 | 14 | 14 | 14 | 13 |
Terminal value at T=10 | 516 | |||||||||
PV of terminal value | 304 | |||||||||
NPV | 156 | |||||||||
Less Debt | 4 | |||||||||
Less Minority Interest | 0 | |||||||||
Equity Value of Firm | 465 | |||||||||
ESG premium/discount | -2% | |||||||||
Target Price per share | 0.74 | |||||||||
Implied FY26F P/E | 11.4% |
Rf4.0%
Beta0.2
Risk premium7.7%
Rm11.7%
TG (%)1.0%
CoE5.7%
CoD4.0%
WACC5.4%
Source: RHB
Recommendation Chart (Textual Representation)
A hypothetical recommendation chart showing “Price Close” and “Recommendations & Target Price” over time from Aug-20 to Feb-25. The chart indicates various “Buy” recommendations with target prices (e.g., 0.99, 1.05, 1.20, 1.12, 1.02) and corresponding prices (e.g., 0.56, 0.59, 0.60, 0.61, 0.57, 0.52). There’s also one “Not Rated” entry at 0.41.
Source: RHB, Bloomberg
Recommendation Chart Table
Date | Recommendation | Target Price | Price |
---|---|---|---|
2025-08-07 | Buy | 0.99 | 0.56 |
2025-05-26 | Buy | 1.05 | 0.59 |
2025-02-26 | Buy | 1.05 | 0.56 |
2025-02-26 | Buy | 1.05 | 0.56 |
2024-08-23 | Buy | 1.20 | 0.60 |
2024-08-22 | Buy | 1.20 | 0.60 |
2024-05-24 | Buy | 1.12 | 0.61 |
2024-02-23 | Buy | 1.02 | 0.57 |
2024-02-07 | Buy | 1.02 | 0.52 |
2021-10-29 | Not Rated | na | 0.41 |
Source: RHB, Bloomberg
See important disclosures at the end of this report
RHB Guide to Investment Ratings
Buy: Share price may exceed 10% over the next 12 months
Trading Buy: Share price may exceed 15% over the next 3 months, however longer-term outlook remains uncertain
Neutral: Share price may fall within the range of +/- 10% over the next 12 months
Take Profit: Target price has been attained. Look to accumulate at lower levels
Sell: Share price may fall by more than 10% over the next 12 months
Not Rated: Stock is not within regular research coverage
Investment Research Disclaimer
RHB Investment Bank Bhd (RHB) has prepared this report for information purposes only. This report is intended for circulation amongst RHB and its affiliates’ clients generally or such persons as may be deemed eligible by RHB from time to time for the receipt of this report. This report is not an offer to sell or a solicitation of an offer to buy any securities or other investment products herein. This report is based on information which it believes to be reliable, but no representation or warranty is made as to its accuracy, completeness or reliability. Opinions expressed in this report are subject to change without notice. RHB and its affiliates accept no liability whatsoever for any direct or consequential loss arising from any use of this report or its contents. All financial products or services mentioned in this report may not be suitable for all investors.
This report may contain forward-looking statements which are often but not always identified by the use of words such as “believe”, “estimate”, “intend” and “expect” and statements that an event or result “may”, “will”, “should”, “could” or “might” occur or be achieved and other similar expressions. Such forward-looking statements are based on assumptions made and information currently available to RHB and are subject to known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievement to be materially different from any future results, performance or achievement expressed or implied by such forward-looking statements. Caution should be exercised in relying on these statements. Any forward-looking statement made in this report or otherwise is subject to the risks and uncertainties found in RHB’s most recent reports or any other publicly available information.
This report may contain information obtained from third parties. Third party content providers do not guarantee the accuracy, completeness, timeliness or availability of any information supplied by the third parties and are not responsible for any errors or omissions or for the results obtained from the use of such content. Third party content providers may be subject to terms and conditions governing their use. RHB hereby disclaims all warranties, express or implied, including, but not limited to, warranties of merchantability and fitness for a particular purpose or use. Third party content providers shall not be liable for any direct, indirect, incidental, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including lost profit or revenue, business interruption, or loss of data) arising out of or relating to your use of this information.
The research analyst(s) responsible for the production of this report hereby certifies that the views expressed herein accurately and completely reflect his or her personal views about the subject company(ies) and any other issuers of securities and/or securities markets. The research analyst(s) also certifies that no part of his or her compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. The research analyst(s) also certifies that no part of his or her compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. The research analyst(s) also certifies that no part of his or her compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. This report is protected by copyright and may not be copied, reproduced, published, distributed, transmitted or passed, in whole or in part, to any other person without the prior express written consent of RHB. This report has been delivered to RHB and its affiliates’ clients for information purposes only and upon the express understanding that such clients will act accordingly. The opinions and recommendations presented in this report do not constitute an offer to sell or a solicitation of an offer to buy any securities or other investment products herein.
Recipients of this report must not reproduce, distribute, publish, or transmit this report, in whole or in part, or any form of this report, for any purpose, without RHB’s prior written consent. The entire report is for the use of the intended recipient only and is not to be distributed to any other party or person.
RHB’s research reports are not intended to be a basis for readers to make their investment decisions. Readers must obtain their own independent professional advice, whether in respect of financial services, legal, accounting, tax or other matters relevant to their investment objectives. The information in this report is not intended to be, nor does it constitute, advice or any recommendation to acquire, dispose of, or subscribe for any investment products or financial services.
The firm has policies and procedures in place to manage conflicts of interest. The research analyst(s) who prepared this report may have been compensated for all or any part of his/her research reports based on factors including but not limited to the firm’s total revenues, an analyst’s productivity, and the quality of an analyst’s research and client service.
Restrictions on Distribution
Malaysia
This report is issued and distributed in Malaysia by RHB Investment Bank Berhad (RHBIB). The views expressed in this report are for information purposes only and subject to change. If the Financial Services and Markets Act of the United Kingdom or the Securities and Futures Act of Hong Kong or any other applicable legislation imposes restrictions on the distribution of this report, then the information contained in this report must therefore not be relied upon as an investment advice based on the regulatory restrictions in that particular country. RHBIB has no obligation to update its opinion or the information contained herein, consider their own investment objective, financial situation or particular needs. RHBIB disclaims all liability for any direct or consequential loss arising from any use of this report or its contents. This report may not be circulated in the United States and Canada.
Indonesia
This report is issued and distributed in Indonesia by PT RHB Sekuritas Indonesia. This report does not constitute an offering document and it should not be construed as an offer, invitation, or solicitation to buy or sell any security in any jurisdiction, including in Indonesia or to any Indonesian citizen or corporation (wherever located) or to any Indonesian resident in a manner which constitutes a public offering under Indonesian laws and regulations must comply with the prevailing Indonesian laws and regulations.
Singapore
This report is issued and distributed in Singapore by RHB Bank Berhad (through its Singapore branch) which is an exempt capital markets services entity and an exempt financial adviser regulated by the Monetary Authority of Singapore. RHB Bank Berhad (through its Singapore branch) may distribute reports produced by its respective foreign entities, affiliates or other foreign research houses pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, RHB Bank Berhad (through its Singapore branch) accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact RHB Bank Berhad (through its Singapore branch) in respect of any matter arising from or in connection with the report.
United States
This report was prepared by RHB is meant for distribution solely and directly to “major” U.S. institutional investors as defined under, and pursuant to, the requirements of Rule 15a-6 under the U.S. Securities and Exchange Act of 1934, as amended (the “Exchange Act”) via a registered U.S. broker-dealer as appointed by RHB from time to time. Accordingly, any access to this report via Bursa Marketplace or any other Electronic Services Provider is not intended for any party other than “major” US institutional investors (via a registered U.S broker-dealer), nor shall be deemed as solicitation by RHB in any manner. RHB is not registered as a broker-dealer in the United States and currently has not appointed a U.S. broker-dealer. Additionally, RHB does not offer brokerage services to U.S. persons. Any order for the purchase or sale of all securities discussed herein must be placed with and through a registered U.S. broker-dealer as appointed by RHB from time to time as required by the Exchange Act Rule 15a-6. For avoidance of doubt, RHB reiterates that it has not appointed any U.S. broker-dealer during the issuance of this report. This report is confidential and not intended for distribution to, or use by, persons other than the recipient and its employees, agents and advisors, as applicable. Additionally, where research is distributed via Electronic Service Provider, the analysts whose names appear in this report are not registered or qualified as research analysts in the United States and are not associated persons of any registered U.S. broker-dealer as appointed by RHB from time to time and therefore may not be subject to any applicable restrictions under Financial Industry Regulatory Authority (“FINRA”) rules on communications with a subject company, public appearances and personal trading. Investing in any non-U.S. securities or related financial instruments discussed in this research report may present certain risks. The securities of non-U.S. issuers may not be registered with, or be subject to the regulations of, the U.S. Securities and Exchange Commission. Information on non-U.S. securities or related financial instruments may be limited. Foreign companies may not be subject to audit and reporting standards and regulatory requirements comparable to those in the United States. The financial instruments discussed in this report may not be suitable for all investors. Transactions in foreign markets may be subject to regulations that differ from or offer less protection than those in the United States.